Related Experiment Video

Updated: May 18, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Stroke prevention in patients with atrial fibrillation: disease burden and unmet medical needs

Carman A Ciervo1, Christopher B Granger, Frederick A Schaller

  • 1Department of Family Medicine, University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine in Stratford, USA. c.ciervo@kennedyhealth.org

The Journal of the American Osteopathic Association
|September 28, 2012
PubMed

Insights

Atrial fibrillation (AF) increases stroke risk and negatively impacts quality of life, especially in older adults. New anticoagulants offer improved safety and efficacy for stroke prevention in AF patients.

Area of Science:

  • Cardiology
  • Geriatrics
  • Public Health

Background:

  • The incidence of atrial fibrillation (AF) is rising with the aging US population.
  • AF significantly increases stroke risk (5-fold), hospitalization rates, and reduces quality of life and work productivity.
  • Current therapeutic decision-making for AF stroke risk is inconsistent due to communication and healthcare access barriers.

Purpose of the Study:

  • To highlight the need for improved evidence-based guidelines in diagnosing, staging, and tracking AF-associated stroke.
  • To discuss the impact of novel anticoagulants on the standard of care for stroke prevention in AF.
  • To emphasize the potential of new anticoagulant agents to improve patient outcomes.

Main Methods:

  • Review of current literature on atrial fibrillation management and stroke risk.
  • Analysis of the impact of aging populations on AF incidence and outcomes.
  • Evaluation of emerging anticoagulant therapies and their clinical implications.

Main Results:

  • Atrial fibrillation poses a substantial and growing public health challenge due to increasing prevalence in aging populations.
  • Existing care pathways for AF stroke risk management show significant variability and are hindered by systemic issues.
  • Novel anticoagulant therapies present a promising advancement in stroke prevention for AF patients, offering enhanced safety and usability.

Conclusions:

  • There is a critical need to implement evidence-based guidelines for AF management to mitigate associated risks.
  • New anticoagulant agents are expected to revolutionize stroke prevention strategies in atrial fibrillation.
  • Improved adherence to guidelines and adoption of novel anticoagulants can enhance patient outcomes and reduce the burden of AF.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...